Sg3 Management, LLC Insmed Inc Call Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$16.98 - $23.15 $254,700 - $347,250
15,000 New
15,000 $299,000
Q3 2021

Nov 15, 2021
SELL
$22.46 - $29.47 $673,800 - $884,100
-30,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$24.17 - $36.01 $725,100 - $1.08 Million
30,000 New
30,000 $854,000
Q1 2021

May 17, 2021
SELL
$32.28 - $44.3 $484,200 - $664,500
-15,000 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$26.0 - $34.5 $390,000 - $517,500
15,000 New
15,000 $482,000

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email